| abstract |
An object of the present invention is to provide a new therapeutic agent and immunosuppressant for hematopoietic tumors with few side effects. A remedy and immunosuppressant for hematopoietic tumors, comprising a compound capable of activating caspase or a pharmaceutically acceptable salt thereof. A molecular targeted therapeutic agent targeting p53, comprising at least one compound selected from the group consisting of capsaicin, caffeine, catechin and derivatives thereof, or a pharmaceutically acceptable salt thereof. [Selection diagram] None |